Every day, hospitals collect medical images, screening results, diagnoses and other health information to support patient care.
This information can also help researchers study diseases, identify patterns and develop better ways to prevent, detect and treat them.
This is the idea behind data altruism: making data available for purposes that benefit society, such as scientific research and better healthcare.
Watch the interview
Data altruism explained
Pierluigi Vacca from Datrix discusses UNICA's citizen-centred approach to data altruism, explaining how voluntarily sharing health data can support medical research, early detection and better healthcare while protecting people's privacy.
Understanding the concept
What is data altruism?
Data altruism means voluntarily making data available for the benefit of society, without expecting a financial reward.
In healthcare, this can mean allowing health information to be used for scientific research, public health activities or the development of new medical technologies.
The European Union gives data altruism a specific meaning under the Data Governance Act. Individuals can voluntarily consent to the use of their personal data, while data holders can make non-personal data available for purposes of general interest, including healthcare and scientific research.
The principle is simple: existing data can help answer important questions and support progress in medicine.
What is health data reuse?
Health data are first collected to support a person's medical care. This is called primary use. The same information may later be used for research. This is known as secondary use.
Primary use
Care for the patient
A doctor uses a mammogram, scan or medical record to assess a patient's health and decide on treatment or further care.
Secondary use
Learn for the future
Researchers analyse eligible health information to study diseases, improve research methods and develop new technologies.
For example, researchers can compare screening records and medical images from different hospitals to study diseases or develop and test AI tools.
This does not mean medical records become public. Their use must follow applicable legal rules and safeguards to protect people's privacy.
Privacy and protection
How is personal health information protected?
Health information is sensitive. Different approaches can help reduce the risk of identifying individuals.
Pseudonymised data
Direct identifiers, such as names, are replaced with a code. A separate key may still link the data to an individual, so they remain personal data under the GDPR.
Anonymised data
Information is processed so that individuals can no longer be identified by means reasonably likely to be used. Truly anonymised data are no longer personal data under the GDPR.
Aggregated data
Researchers receive summaries or statistics about groups of people rather than individual records.
An important distinction
Removing a person's name does not automatically make data anonymous. Protection must be assessed carefully, especially for detailed medical images and information about rare conditions.
Data protection also means controlling access, limiting use to approved purposes and applying appropriate technical and organisational safeguards.
The wider impact
Who benefits from data altruism?
Responsible health data reuse can benefit many people, not only those whose information is used.
Patients and future patients
Research can support better screening, earlier detection, more accurate diagnosis and new treatment approaches. The benefits are often collective and may help future patients.
Researchers and scientists
Data from different hospitals and populations help researchers identify patterns and investigate questions that one hospital alone may not be able to answer.
Doctors and healthcare professionals
Research and properly validated technologies can support doctors in analysing medical images and making clinical decisions. AI does not replace medical professionals.
Hospitals and healthcare systems
Sharing knowledge across centres can help evaluate services, improve screening programmes and support healthcare planning.
Society as a whole
Health data can support better public health decisions and more representative medical research and innovation.
Sharing data alone does not guarantee better outcomes. Research quality and responsible use remain essential.
A closer look
What does this mean for cancer research?
Mammograms, X-rays, CT scans and MRI images help researchers study how cancers develop and how they can be detected.
When eligible data from different hospitals are available for research, scientists can work with larger and more diverse datasets. This can support the development and testing of new methods, including AI-based tools for cancer image analysis.
The UNICA project
Connecting hospitals to support cancer research
UNICA aims to extend the European Cancer Imaging Initiative by connecting 12 medical centres across Europe and making breast, lung and prostate cancer screening data available through the EUCAIM federated infrastructure.
The project aims to support research and innovation in cancer screening and early detection.
Informed choices
How can you contribute to data altruism?
Data altruism relies on trust and transparency. In initiatives using a formal data altruism model, individuals may be invited to give informed consent for the use of their personal data.
Before making a decision, people should understand:
01. What data will be used and why.
02. Who will be able to access them.
03. How the information will be protected.
04. What rights and choices are available.
Consent is one possible legal route for data altruism, but not every research project uses it. Depending on the purpose, data and applicable national rules, health data may also be reused under other legal bases and safeguards.
From principle to practice
How does this work in UNICA?
UNICA does not ask patients to send their medical records or images directly to the project. A separate UNICA-wide patient data donation consent form is not currently part of the data-sharing process.
Participating hospitals follow their own legal and organisational procedures to make eligible screening data available for research. Each hospital determines which data can be used and under which legal basis.
Data are handled through controlled processes and appropriate safeguards. Depending on the approved pathway, they may be pseudonymised or anonymised.
How federated AI works
The data stay at the hospital
In UNICA's federated AI activities, patient-level data remain at the hospital. Centres exchange model updates rather than transferring their raw patient datasets for that training process.
UNICA's data altruism campaign is informative. It explains why responsible health data reuse matters, how it can support cancer research and how privacy is protected. 81Watts, with its recognised expertise in data altruism at the European level, leads these activities within the project.
Your role
What can you do?
Stay informed, ask questions and take part in discussions about the future of healthcare research.
If you are a patient at one of the participating hospitals and want to know whether your health information may be used for research, contact your hospital or its Data Protection Officer. They can explain how data are used, how they are protected and what rights and choices are available to you.
A simple but important point
You do not need to send your medical records to UNICA.
Data for the common good
Better healthcare research starts with informed choices, transparency and trust.
Responsible health data reuse can help research move forward, while protecting people's rights and privacy.
